The FDA has approved a groundbreaking blood test, Lumipulse, that detects amyloid plaques linked to Alzheimer’s disease, offering a safer, more accessible diagnostic tool for millions.
In a surprising turn of events, Elizabeth Holmes' partner, Billy Evans, raises millions for an AI startup named Haemanthus, aimed at revolutionizing medical testing. As Holmes advises from prison, the venture seeks to make advanced diagnostic tools accessible to patients.
